A5015841244- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Data Mining and Machine Learning Applications
- Computer Science and Engineering
- Sarcoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
RSUD Prof. Dr. Saiful Anwar Malang
2024
University of Brawijaya
2024
Introduction. Immunotherapy has been widely used in the treatment of various malignancies with satisfactory results. One agents for immunotherapy is an inhibitor programmed cell death-1 and its ligands (PD-1 PD-L1). However, attempts at utilizing PD-1/PD-L1 osteosarcoma have not yielded favorable This may be due to differences PD-L1 regulation immune landscape osteosarcoma, as mechanism still poorly understood. Therefore, elucidating paramount order improve results using immunotherapy....
Lymphomas are malignant lymphocyte neoplasms that globally account for 10% of cancers in individuals aged <20 years. Malignant lymphomas divided into Hodgkin's lymphoma (HL) and non-Hodgkin's (NHL). Despite the availability many therapeutic modalities lymphoma, such as
Lymphomas are a lymphocyte-driven malignancy that comprise up to 10% of cancers diagnosed in individuals < 20 years age globally. Malignant lymphomas divided into Hodgkin Lymphoma (HL) and Non (NHL). In 2019 at United States, more than 82.000 new patients with lymphoma. Since the epidemiology is different across regions may have change over time, its global distribution pattern, risk factors, temporal trends need be assessed for developing preventive measures. The purpose this study was...